• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Personalis, Inc. - Common Stock (NQ: PSNL )

    5.050 +0.160 (+3.27%)
    Streaming Delayed Price Updated: 4:00 PM EST, Feb 4, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Personalis, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 7 Next >
    Personalis to Participate at the BTIG Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
    From Personalis, Inc.
    Via Business Wire
    Personalis Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)
    Via Benzinga
    New Nature Medicine Publication Shows ctDNA Levels Linked to Recurrence Risk in Lung Cancer
    From Personalis, Inc.
    Via Business Wire
    Personalis Reports Preliminary Fourth Quarter and Full Year 2024 Revenue
    From Personalis, Inc.
    Via Business Wire
    Key Takeaways From Personalis Analyst Ratings
    Via Benzinga
    What Analysts Are Saying About Personalis Stock
    Via Benzinga
    Assessing Personalis: Insights From 4 Financial Analysts
    Via Benzinga
    Dow Surges Over 600 Points, Gold Jumps 1.5%
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Oncology Advancements Accelerate Amid Rising Early-Onset Cancer Diagnoses
    EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:CRDF),(NASDAQ:PSNL),(NASDAQ:TEM),(NASDAQ:CKPT) EQNX::TICKER_END 
    Via FinancialNewsMedia
    Topics Artificial Intelligence
    Exposures Artificial Intelligence COVID-19
    Nasdaq Jumps Over 300 Points, Novo Nordisk Shares Spike Higher
    Via Benzinga
    Mission Produce, Nvidia, Humacyte, BlackBerry And Other Big Stocks Moving Higher On Friday
    Via Benzinga
    Stock Of The Day: Where Does The Merck Downtrend End?
    Shares of Merck & Co (MRK) continue to trend lower. If they reach the $95.00 level, there is a good chance they find support and reverse. 
    Via Benzinga
    Personalis Advances Business Strategy with Investment from Merck and Extends Collaboration with Moderna
    From Personalis, Inc.
    Via Business Wire
    Personalis and Tempus Expand Collaboration to Biopharma
    From Personalis, Inc.
    Via Business Wire
    Personalis to Participate at Upcoming Investor Conferences
    From Personalis, Inc.
    Via Business Wire
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Personalis Reports Third Quarter 2024 Financial Results
    From Personalis, Inc.
    Via Business Wire
    Personalis to Present at the Stifel 2024 Healthcare Conference
    From Personalis, Inc.
    Via Business Wire
    Personalis to Announce Third Quarter 2024 Financial Results
    From Personalis, Inc.
    Via Business Wire
    ESMO 2024 Data Expands on Compelling Performance of Personalis NeXT Personal® MRD Test
    From Personalis, Inc.
    Via Business Wire
    Biotech Stock Soars 60% in 2024: Cathie Wood’s Bold Investment
    Tempus AI is a hot healthcare stock that investors should be aware of. It is using AI to pursue "precision medicine", especially in cancer research. 
    Via MarketBeat
    Topics Artificial Intelligence ETFs
    Exposures Artificial Intelligence
    Personalis to Participate at Upcoming Investor Conferences
    From Personalis, Inc.
    Via Business Wire
    Why Tempus AI Stock Skyrocketed Nearly 22% Today
    It deepened its involvement in a client and peer. 
    Via The Motley Fool
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Personalis, Inc.
    Via Business Wire
    Personalis and Tempus Announce Expanded Collaboration
    From Personalis, Inc.
    Via Business Wire
    PSNL Stock Earnings: Personalis Beats EPS, Beats Revenue for Q2 2024
    PSNL stock results show that Personalis beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
    Via InvestorPlace
    Personalis Reports Second Quarter 2024 Financial Results
    From Personalis, Inc.
    Via Business Wire
    Myriad Genetics Reports Strong Second Quarter 2024 Financial Results, including 15% Revenue Growth Year-Over-Year; Raises 2024 Financial Guidance and Long-Term Revenue Growth Target to 12%
    From Myriad Genetics, Inc.
    Via GlobeNewswire
    Personalis to Participate at the 9th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference
    From Personalis, Inc.
    Via Business Wire
    < Previous 1 2 3 4 5 6 7 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.